Refractive Surgery News Today

/PRNewswire/ -- Myra Vision, a Shifamed portfolio company, announced today its Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System, a next-generation...

VERMILLION — Vance Thompson ’82, ’86, M.D., founder of Vance Thompson Vision and director of refractive surgery and University of South Dakota alumnus, will deliver the commencement address at the

REFINITIV STREETEVENTS EDITED TRANSCRIPT Q1 2024 Johnson & Johnson Earnings Call EVENT...

Shares of Moderna (NASDAQ: MRNA) rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157/V940, its investigational individualized neoantigen therapy, in certain patients with head and neck cancer.

For two decades, MIT-Mexico has funded student internships and teaching, as well as faculty research collaborations.

CRANBURY - Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today...

Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with...

Thompson will assume the presidency of the ASCRS, which is celebrating its 50th anniversary in 2024. The organization kicks off its 2024 annual meeting Friday at Boston Convention and Exhibition Center in Boston.

/PRNewswire/ -- ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm,...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today...